FOXD1 upregulates DARS2-mediated glycolysis to drive cisplatin resistance in bladder cancer

Urologic Oncology: Seminars and Original Investigations · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles